REQUEST A DEMO
Total
USD $0.00
Search more companies

Jindal Medicines Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jindal Medicines Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Jindal Medicines Pvt Ltd is a company based in India, with its head office in Jalandhar. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on November 07, 1989. The company’s latest financial report indicates a net sales revenue increase of 5.88% in 2025. Over the same period, its total assets grew by 0.25%. In, 2025, the company’s net profit margin increased by 0.06%.

Legal Address
78- Arjan Nagar
Jalandhar; Punjab; Postal Code: 144001

Contact Details: Purchase the Jindal Medicines Pvt Ltd report to view the information.

Basic Information
Registered Capital:
Purchase the Jindal Medicines Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Jindal Medicines Pvt Ltd report to view the information.
Incorporation Date:
November 07, 1989
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Jindal Medicines Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
5.88%
Total Operating Revenue
5.98%
Operating Profit
16.89%
EBITDA
5.57%
Net Profit/Loss for the Period
22.19%
Total Assets
0.25%
Total Equity
15.73%
Operating Profit Margin
0.14%
Net Profit Margin
0.06%
Return on Equity (ROE)
0.91%
Debt / Equity
7.78%
Quick Ratio
0.62%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?